Clincosm LogoSign in Get a demo

gynecological malignancies

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Menopausal Status in Gynecological Malignancy After Ovariectomy

Not yet recruiting
  • Gynecological Malignancies
  • +2 more
  • No intervention
  • (no location specified)
Nov 28, 2023

Gynecological Malignancies Trial in Beijing (BL-M07D1)

Not yet recruiting
  • Gynecological Malignancies
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 15, 2023

Immunotherapy-related CRP Kinetics in Metastatic Gynecological

Recruiting
  • Gynecological Malignancies
  • +4 more
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    A Multicenter Prospective Post-registration Study of

    Recruiting
    • Solid Tumor
    • +5 more
    • Moscow, Not Required, Russian Federation
    • +2 more
    May 31, 2021

    Gynecological Malignancies Trial in Hadera (Mid-Infrared Spectroscopy with ATR)

    Unknown status
    • Gynecological Malignancies
    • Mid-Infrared Spectroscopy with ATR
    • Hadera, Israel
      Hillel Yaffe Medical Center
    Mar 21, 2016

    Cancer, Carcinoma, Fallopian Tube Cancer Trial in Australia, Belgium, United States (A1: AMG 386 10 mg/kg + Liposomal

    Completed
    • Cancer
    • +8 more
    • A1: AMG 386 10 mg/kg + Liposomal doxorubicin
    • +3 more
    • Tucson, Arizona
    • +15 more
    Sep 25, 2015

    Gynecological Malignancies, Genital Tumors, Female, Anemia Trial (darbepoetin alfa, recombinant human erythropoietin (rHuEPO))

    Completed
    • Gynecological Malignancies
    • +2 more
    • darbepoetin alfa
    • recombinant human erythropoietin (rHuEPO)
    • (no location specified)
    Dec 20, 2007